Skip to main content
. 2022 Jul 18;10(7):1731. doi: 10.3390/biomedicines10071731

Figure 3.

Figure 3

Crystallographic grids of DIZE and candesartan incorporation into the cavity of the SARS-CoV-2 spike protein. (A1) DIZE and (A2) candesartan incorporated into a cavity of Mpro of SARS-CoV-2 (PDB ID: 6LU7) using a crystallographic grid. (B1) DIZE and (B2) candesartan incorporated into a cavity of spike protein RBD (PDB ID: 6LZG) of SARS-CoV-2 using a crystallographic grid. (C1) DIZE and (C2) candesartan incorporated into a cavity of spike protein RBD (PDB ID: 7DDN) of SARS-CoV-2 using a crystallographic grid. (D1) DIZE and (D2) candesartan incorporated into a cavity of AT1R (PDB ID: 4YAY) using a crystallographic grid.